Andreas Halvorsen – BMRN history
- Issuer:
- BIOMARIN PHARMACEUTICAL INC
- Quarters tracked:
- 21 (Q4 2021 → Q1 2026)
- Current shares:
- 7,062,077
- Current value:
- $398.94M
- Peak shares:
- 12,288,611 (Q2 2025)
- Overall change:
- +146%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | 7,062,077 | $398.94M | $56.49 | +1,025,141 | +17% |
| Q4 2025 | 6,036,936 | $358.77M | $59.43 | -2,285,243 | -27% |
| Q3 2025 | 8,322,179 | $450.73M | $54.16 | -3,966,432 | -32% |
| Q2 2025 | 12,288,611 | $675.50B | $54970.00 | 0 | 0% |
| Q2 2025 | 12,288,611 | $675.50M | $54.97 | +1,488,552 | +14% |
| Q1 2025 | 10,800,059 | $763.46M | $70.69 | 0 | 0% |
| Q1 2025 | 10,800,059 | $763.46B | $70690.00 | +289,509 | +3% |
| Q4 2024 | 10,510,550 | $690.86M | $65.73 | 0 | 0% |
| Q4 2024 | 10,510,550 | $690.86B | $65730.00 | +757,257 | +8% |
| Q3 2024 | 9,753,293 | $685.56M | $70.29 | +2,689,729 | +38% |
| Q2 2024 | 7,063,564 | $581.54M | $82.33 | +647,276 | +10% |
| Q1 2024 | 6,416,288 | $560.40M | $87.34 | +1,526,834 | +31% |
| Q4 2023 | 4,889,454 | $471.44B | $96420.00 | +673,998 | +16% |
| Q3 2023 | 4,215,456 | $372.98B | $88480.00 | +58,671 | +1% |
| Q2 2023 | 4,156,785 | $360.31B | $86680.00 | +1,988,168 | +92% |
| Q1 2023 | 2,168,617 | $210.88B | $97240.00 | -3,105,003 | -59% |
| Q4 2022 | 5,273,620 | $545.77M | $103.49 | +174,456 | +3% |
| Q3 2022 | 5,099,164 | $432.26M | $84.77 | +46,571 | +1% |
| Q2 2022 | 5,052,593 | $418.71M | $82.87 | +1,300,200 | +35% |
| Q1 2022 | 3,752,393 | $289.31M | $77.10 | +882,446 | +31% |
| Q4 2021 | 2,869,947 | $253.56M | $88.35 | — | NEW |